EA202191931A1 - Способ характеризации видимых и/или невидимых частиц в биологических препаратах - Google Patents

Способ характеризации видимых и/или невидимых частиц в биологических препаратах

Info

Publication number
EA202191931A1
EA202191931A1 EA202191931A EA202191931A EA202191931A1 EA 202191931 A1 EA202191931 A1 EA 202191931A1 EA 202191931 A EA202191931 A EA 202191931A EA 202191931 A EA202191931 A EA 202191931A EA 202191931 A1 EA202191931 A1 EA 202191931A1
Authority
EA
Eurasian Patent Office
Prior art keywords
visible
characterizing
biological preparations
invisible
invisible particles
Prior art date
Application number
EA202191931A
Other languages
English (en)
Inventor
Сяобинь Сюй
Original Assignee
Ридженерон Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ридженерон Фармасьютикалз, Инк. filed Critical Ридженерон Фармасьютикалз, Инк.
Publication of EA202191931A1 publication Critical patent/EA202191931A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • H01J49/0031—Step by step routines describing the use of the apparatus
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/02—Details
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

В данном изобретении предложен способ характеризации или количественного определения одного или более белков в видимых и/или невидимых частицах, образованных в образце, путем обнаружения по меньшей мере одной видимой или невидимой частицы в образце, выделения и захвата по меньшей мере одной видимой или невидимой частицы для определения присутствия белка и использование масс-спектрометра для характеризации белка.
EA202191931A 2019-01-30 2020-01-29 Способ характеризации видимых и/или невидимых частиц в биологических препаратах EA202191931A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962798750P 2019-01-30 2019-01-30
PCT/US2020/015699 WO2020160161A1 (en) 2019-01-30 2020-01-29 Method of characterization of visible and/or sub-visible particles in biologics

Publications (1)

Publication Number Publication Date
EA202191931A1 true EA202191931A1 (ru) 2022-02-14

Family

ID=69846159

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191931A EA202191931A1 (ru) 2019-01-30 2020-01-29 Способ характеризации видимых и/или невидимых частиц в биологических препаратах

Country Status (14)

Country Link
US (3) US11187707B2 (ru)
EP (1) EP3918340A1 (ru)
JP (1) JP7466553B2 (ru)
KR (1) KR20210121107A (ru)
CN (1) CN113454460B (ru)
AU (1) AU2020214797A1 (ru)
BR (1) BR112021013734A2 (ru)
CA (1) CA3126710A1 (ru)
EA (1) EA202191931A1 (ru)
IL (1) IL284885A (ru)
MX (1) MX2021009264A (ru)
SG (1) SG11202108031VA (ru)
WO (1) WO2020160161A1 (ru)
ZA (1) ZA202105176B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3126710A1 (en) * 2019-01-30 2020-08-06 Regeneron Pharamaceuticals, Inc. Method of characterization of visible and/or sub-visible particles in biologics
WO2022209422A1 (ja) * 2021-03-30 2022-10-06 富士フイルム株式会社 精製状態の推定方法
WO2024052440A1 (en) 2022-09-09 2024-03-14 F. Hoffmann-La Roche Ag Inspection system and method for a closed medical container
CN116563244B (zh) * 2023-05-11 2024-04-23 中国食品药品检定研究院 一种亚可见颗粒质控方法、系统及设备

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
CN1262667C (zh) * 1996-04-25 2006-07-05 詹尼康科学公司 利用颗粒标记物检测分析物
US6547828B2 (en) * 2001-02-23 2003-04-15 Smith & Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for medical implant use
US20050148098A1 (en) * 2003-12-30 2005-07-07 Xing Su Methods for using raman spectroscopy to obtain a protein profile of a biological sample
US20100216969A1 (en) * 2005-06-27 2010-08-26 Bionanophotnics A/S Immobilisation of polypeptides by irradiation
US20070134814A1 (en) * 2005-12-09 2007-06-14 Kajander E O Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
EP1991694B1 (en) * 2006-02-13 2016-04-13 Fluidigm Canada Inc. Element-tagged oligonucleotide gene expression analysis
WO2008141230A1 (en) * 2007-05-09 2008-11-20 Lawrence Livermore National Security, Llc Methods and systems for monitoring production of a target protein in a nanolipoprotein particle
US8147735B2 (en) * 2008-07-09 2012-04-03 Eltron Research & Development, Inc. Semipermeable polymers and method for producing same
EP2802871B1 (en) * 2012-01-11 2022-07-27 Takeda Pharmaceutical Company Limited Characterization of subvisible particles using a particle analyzer
EP2929050A1 (en) * 2012-12-10 2015-10-14 AdvanDx, Inc. Use of probes for mass spectrometric identification of microorganisms or cells and associated conditions of interest
TWI670279B (zh) * 2013-03-15 2019-09-01 美商艾爾德生物製藥股份有限公司 抗體純化及純度監測
CA2910065C (en) * 2013-05-15 2023-09-19 Medimmune Limited Purification of recombinantly produced polypeptides
JP6400086B2 (ja) * 2013-06-05 2018-10-03 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド バイオ医薬品タンパク質製品における宿主細胞タンパク質夾雑物の検出のためのｓｗａｔｈデータ独立取得テクノロジ
JP6687618B2 (ja) * 2014-08-15 2020-04-22 メディミューン，エルエルシー 組換えタンパク質調製物中の残留宿主細胞タンパク質の検出
EP3218479A1 (en) * 2014-11-11 2017-09-20 Nanocore ApS Method for identification of molecules with desired characteristics
CN108026164A (zh) * 2015-09-24 2018-05-11 梅约医学教育与研究基金会 通过质谱鉴定免疫球蛋白游离轻链
EP3427024A4 (en) * 2016-02-18 2019-11-06 Optofluidics, Inc. SYSTEM AND METHOD FOR CHARACTERIZING PARTICLES IN A LIQUID SAMPLE
TWI760345B (zh) * 2016-07-05 2022-04-11 法商賽諾菲公司 抗體調配物
US11390840B2 (en) * 2016-09-30 2022-07-19 University Of Florida Research Foundation, Inc. Systems and methods including porous membrane for low-voltage continuous cell electroporation
WO2018213331A1 (en) * 2017-05-16 2018-11-22 Lankenau Institute For Medical Research Compositions comprising ligands to rhob protein and the uses thereof
CA3126710A1 (en) * 2019-01-30 2020-08-06 Regeneron Pharamaceuticals, Inc. Method of characterization of visible and/or sub-visible particles in biologics

Also Published As

Publication number Publication date
US20230273219A1 (en) 2023-08-31
US11187707B2 (en) 2021-11-30
KR20210121107A (ko) 2021-10-07
BR112021013734A2 (pt) 2021-09-21
SG11202108031VA (en) 2021-08-30
AU2020214797A1 (en) 2021-08-12
US20200241002A1 (en) 2020-07-30
ZA202105176B (en) 2023-10-25
CA3126710A1 (en) 2020-08-06
IL284885A (en) 2021-08-31
CN113454460A (zh) 2021-09-28
MX2021009264A (es) 2021-08-24
JP2022519226A (ja) 2022-03-22
WO2020160161A1 (en) 2020-08-06
US11693010B2 (en) 2023-07-04
EP3918340A1 (en) 2021-12-08
CN113454460B (zh) 2024-06-11
US20220034905A1 (en) 2022-02-03
JP7466553B2 (ja) 2024-04-12

Similar Documents

Publication Publication Date Title
EA202191931A1 (ru) Способ характеризации видимых и/или невидимых частиц в биологических препаратах
DE602007011937D1 (de) Peptidantikörperdepletion und anwendung zur probenvorbereitung für massenspektrometrie
EA201992748A1 (ru) Диагностические анализы для обнаружения, количественного определения и/или отслеживания микроорганизмов и других аналитов
BR112017018821A2 (pt) métodos para quantificação de níveis de insulina através de espectrometria de massa
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
EA201892325A1 (ru) Композиции и способы детектирования белков клетки-хозяина
EA201491974A1 (ru) Количественное определение примесей для промышленного тестирования пептидных продуктов
TR201905062T4 (tr) Erken granüle hücrelerin (EGC'ler) tanımlanması ve sayılması.
MX2018009339A (es) Métodos para la identificación y análisis de secuencias de aminoácidos de las proteínas.
Di Venere et al. Ixodes ricinus and its endosymbiont Midichloria mitochondrii: a comparative proteomic analysis of salivary glands and ovaries
PH12020551371A1 (en) Assays to detect neurodegeneration
EA202092203A1 (ru) Способы анализа и реагенты для микрочипового капиллярного электрофореза
BR112021020378A2 (pt) Identificação de proteínas de célula hospedeira
MA46814A1 (fr) Anticorps anti-lag3 radiomarqués pour imagerie immuno-pet
WO2021021964A3 (en) Methods of quantifying frataxin and frataxin fusion proteins
EP4300101A3 (en) Antigenic peptides and uses thereof for diagnosing and treating autism
SG11201907866SA (en) Horseshoe crab factor b variant
MX2016016222A (es) Sistemas y metodos para detectar y demostrar daño por radiacion ultravioleta al cabello mediante la evaluacion de fragmentos de proteina.
UA112515C2 (uk) Спосіб виявлення присутності двох або більше білків, що становлять інтерес, в зразках рослинного походження
MX2021007518A (es) Metodo de extraccion de proteina a partir de material vegetal de cannabis.
GB2554282A (en) Lock mass library for internal correction
EP4253950A3 (en) Ce-western applications for antibody development
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
WO2019066572A3 (en) Method and device for analyzing target analyte in sample
ZA202203400B (en) Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysis